Litigator of the Week

Michael Kimberly of Mayer Brown.

Litigator of the Week: Michael Kimberly of Mayer Brown

By Zoe Tillman |

For most litigators, a win at the U.S. Supreme Court is a career highlight. And so it was for Mayer Brown partner Michael Kimberly, who in December won a unanimous ruling that revived a lawsuit accusing Maryland officials of partisan gerrymandering. But Kimberly said that his latest win in the lower court after the justices sent the case back was actually more exciting.

Kirt O'Neill, partner at Akin Gump.

Litigator of the Week: Kirt O’Neill of Akin Gump Strauss Hauer & Feld

By John Council |

Defending a company accused of monopolizing an unusual but lucrative segment of the bovine industry in the heart of dairy country is no easy task--but Akin Gump's Kirt O'Neill delivered.

Adam Alper and Mike DeVries of Kirkland & Ellis.

Litigators of the Week: Adam Alper and Michael De Vries of Kirkland & Ellis

By Scott Graham |

Trial was only seven months away when Energy Labs Inc. brought in Kirkland & Ellis last fall to defend a patent suit by a rival air conditioning company. It was a bet-the-company case in a multi-billion dollar market--and the Kirkland team delivered.

Paul Clement of Bancroft and Richard Marooney of King & Spalding (Diego M. Radzinschi/ALM, Handout).

Litigators of the Week: Richard Marooney Jr. of King & Spalding and Paul Clement of Bancroft PLLC

By Scott Flaherty |

Most lawsuits don’t present American judges with the choice of whether to defer to a foreign court ruling. But that’s the unique situation that arose in a KBR Inc. subsidiary’s contract dispute with Mexico’s state-owned oil company, Pemex.

L-R Fank Libby and Reid Weingarden

Litigators of the Week: Reid Weingarten of Steptoe & Johnson LLP and Frank Libby of LibbyHoopes

By Suzanne Monyak |

As the end of a six-week trial approached, Steptoe & Johnson LLP partner Reid Weingarten and LibbyHoopes partner Frank Libby had a decision to make: whether to put their clients on the stand. It turns out, their instincts were right.

Joshua Rosenkranz of Orrick, Herrington & Sutcliffe. HANDOUT.

Litigator of the Week: E. Joshua Rosenkranz of Orrick, Herrington & Sutcliffe

By Scott Flaherty |

How Joshua Rosenkranz guided Microsoft Corp. to victory in a case that raised largely untested questions about the reach of U.S. law enforcement in the age of cloud computing.

Litigator of the Week: Paul Reichler of Foley Hoag

By Michael D. Goldhaber |

Paul Reichler has been dubbed Mr. World Court for his dominance at the seat of public international law. But in the past week Mr. World Court became Mr. Arbitration. It was a great week for public health and maritime borders. And a terrible week for international bullies.

Jeff Thomas of Gibson, Dunn & Crutcher LLP (HANDOUT).

Litigator of the Week: Jeffrey Thomas of Gibson, Dunn & Crutcher

By Ben Hancock |

Jeffrey Thomas knew how he had to set it up. After working for years on Hewlett-Packard’s breach of contract suit against Oracle Corp., his strategy was clear when the phase-two jury trial began this May, with $3 billion on the line.

Hank Asbill & Noel Francisco of Jones Day (Asbill: Courtesy photo. Francisco: Diego M. Radzinschi / NLJ).

Litigators of the Week: Henry Asbill and Noel Francisco of Jones Day

By Zoe Tillman |

By the time former Virginia governor Robert McDonnell was indicted on public corruption charges in January 2014, his lawyers at Jones Day already had their eye on the U.S. Supreme Court.

Cris Arguedas.

Litigator of the Week: Cristina Arguedas of Arguedas, Cassman & Headley

By Ross Todd |

It's hard to overstate how good Cristina Arguedas was last week during opening arguments in defense of FedEx Corp. Just four days later, prosecutors abruptly dropped the case at the end of the first week of a bench trial with $1.6 billion on the line.

David Dahlquist at Winston & Strawn and Robby Robertson at Hogan Lovells (HANDOUTS).

Litigators of the Week: David Dahlquist of Winston & Strawn and J. Robert Robertson of Hogan Lovells

By Amanda Bronstad |

David Dahlquist and J. Robert Robertson handed the Federal Trade Commission a rare loss in a hospital merger case.

Jonathan Singer, Fish & Richardson.

Litigator of the Week: Jonathan Singer of Fish & Richardson

By Scott Graham |

When a Merck & Co. in-house attorney recanted his deposition testimony in a patent brawl over Hepatitis C medications, Fish & Richardson lawyers knew they had an opening. Jonathan Singer used it to get a $200 million verdict thrown out.

Robert Van Nest and Christa Anderson of Keker & Van Nest (HANDOUT).

Litigators of the Week: Robert Van Nest and Christa Anderson of Keker & Van Nest

By Scott Flaherty |

With $9 billion on the line, Google Inc. never lost faith in its lawyers at Keker & Van Nest.

Kannon Shanmugam, left, and Joshua Rosenkranz.

Litigators of the Week: Kannon Shanmugam of Williams & Connolly and Joshua Rosenkranz of Orrick

By Scott Flaherty |

The pair knocked out a billion-dollar judgment against Bank of America that had stood out as a bright spot for prosecutors in the wake of the financial crisis.

Gary Naftalis of Kramer Levin

Litigator of the Week: Gary Naftalis of Kramer Levin Naftalis & Frankel

By Scott Flaherty |

Litigators like to tout their track record in "bet-the-company" cases. But how many lawyers can claim a victory in "bet-the-temple" litigation?

Litigator of the Week: Tariq Mundiya of Willkie Farr & Gallagher

By Scott Flaherty |

A pair of board-friendly wins for Mundiya in New York and Delaware makes it tougher for shareholders challenging going-private transactions.

George Cary

Litigator of the Week: George Cary of Cleary Gottlieb

By Scott Flaherty |

Dispatching a multibillion-dollar threat to Sanofi-Aventis, Cary polished off claims that the company blocked rival drugmakers from competing to sell blood thinners to hospitals nationwide.

Shannon Liss-Riordan

Litigator of the Week: Shannon Liss-Riordan of Lichten & Liss-Riordan

By Scott Flaherty |

She’s been labeled a scourge of the sharing economy and a protector of its workers. Either way, Liss-Riordan isn’t going away.

Rick Richmond

Litigator of the Week: Rick Richmond of Jenner & Block

By Scott Flaherty |

Richmond's $940 million jury verdict for Epic System is one of the largest ever in a trade secrets case.

Michael Paskin, attorney for Argentina, leaves the U.S. Court of Appeals for the Second Circuit, April 12, 2016. The court on April 13 cleared Argentina to make payments on its debt, paving the way for the country to settle its long battle over bonds defaulted in 2001.

Litigators of the Week: Michael Paskin of Cravath and Paul Clement of Bancroft

By Scott Flaherty |

After a change in government and a change of lawyers, the end of Argentina’s long battle with bondholders may finally be near.

Mark Cheffo

Litigator of the Week: Mark Cheffo of Quinn Emanuel

By Scott Flaherty |

Product liability litigation against drug companies often hinges on the science. But when it comes to convincing a judge that the science is bad, it’s all about the lawyers.

Eugene Scalia.

Litigator of the Week: Eugene Scalia of Gibson, Dunn & Crutcher

By Jenna Greene |

Eugene Scalia has long been known as a regulation killer, the go-to lawyer for attacking government overreach. This week, the Gibson, Dunn & Crutcher partner slayed one of his biggest dragons yet: the designation of MetLife Inc. as a “systemically important financial institution.”

Steven Zalesin

Litigator of the Week: Steven Zalesin of Patterson Belknap

By Scott Flaherty |

Regrouping after a setback at the Supreme Court, Steven Zalesin cleared Coca-Cola of long-standing false advertising claims by juice-maker POM Wonderful.

Litigator of the Week: James Rouhandeh of Davis Polk

By Scott Flaherty |

Rouhandeh’s persistence paid off in lingering litigation tied to $7 billion Ponzi scheme, to the great relief of his law firm client, Proskauer Rose.

John Neuwirth

Litigator of the Week: John Neuwirth of Weil, Gotshal & Manges

By Scott Flaherty |

In his second securities class action win for drugmaker Sanofi this year, Neuwirth dissuaded the Second Circuit from taking a plaintiffs-friendly view of the Supreme Court’s decision in Omnicare.